Organization appraisal system company vigorously strengthen safety risk prevention and control
Release time:
2022-03-22
News from our newspaper The prevention and control and evaluation of safety risks is an important part of the company's safety production management in the past two years. In order to further strengthen the safety risk prevention awareness of all employees and improve the safety management level, the company has carried out three consecutive years of safety risk prevention and control evaluation of the winning enterprises starting from 2022 , and at the same time formulated and issued the "Operation Safety Risk Assessment and Control System". It has been incorporated into the company's internal control management system.
safety risk prevention and control of the winning enterprise evaluation, is in the two phase safety and environmental protection accident-free factory created on the basis. From 2014 to 2016 , 2017 to 2021 , the company has successively carried out two phases of safety and environmental protection accident-free factory creation work in the whole group's production units, which has better promoted the standardization and standardization of safety and environmental protection management in the whole group. In order to further do a good job in safety production management and protect the lives and health of employees, the company decided to carry out safety risk prevention and control evaluation activities based on the experience of creating an "accident-free factory. The enterprises included in the appraisal are the production department of the group's subordinate enterprises and pharmaceutical companies, Anhui Xinbeika Chemical, Jianfeng Beika Pharmaceutical and other pharmaceutical plate manufacturers. The selection is led by the safety management office of the group company, and will be evaluated once a year at the end of the year starting from 2022 , with a tentative period of three years. According to the annual safety management results of each participating unit and the on-site safety supervision of the group company, the annual scores of each enterprise are calculated by combining qualitative and quantitative methods, and are ranked from high to low. After being approved by the company's safety committee, the top three enterprises that meet the conditions will be rewarded.
activity scoring rules are divided into qualitative and quantitative parts, of which the qualitative part is the necessary condition for winning the award, including the establishment of safety risk prevention and control mechanism and normal implementation, the comprehensive signing of safety production responsibility system, and no fire and explosion accidents with direct economic losses of more than 10 yuan, no direct economic loss of more than 10 yuan or more than 9 (inclusive) work-related accidents, no concealment of safety accidents, annual evaluation score of 70 or more, any failure to do so, are not allowed to participate in the evaluation of enterprises with superior safety risk prevention and control; The quantitative part includes the implementation of safety inspection, training, activities, etc.
Company requires that all units formulate implementation rules in combination with the actual situation of the enterprise, earnestly do a good job in public opinion publicity and safety risk prevention and control training, publicize the importance of safety risk prevention and control work and the harmfulness of accidents to employees, guide employees to consciously implement safety risk prevention and control measures, and improve the ability of safety risk prevention and control; Consolidate the previous achievements of employees' work safety education, and put 50 articles on "Typical Violations, as a normalized safety education content, employees are required to master and use it proficiently to avoid illegal operations; improve and refine safety risk prevention and control measures, strengthen the inspection and assessment of the implementation process, and strive for the continuous, stable and good development of the safety management situation.
The "Operation Safety Risk Assessment and Control System" recently introduced the management goal of standardizing operation safety procedures, effectively controlling the safety risks of various operations, and achieving "zero injury. The types and scope of operations included in safety risk control include equipment repair, technical renovation and installation works, temporary object handling and unloading, equipment blocking, warehouse cleaning, civil construction, trial production of new equipment, new products, new processes and new materials, pilot test of product development, etc., and other types of operations other than daily productive routine operations. These operation items shall be subject to safety risk assessment first, risk level shall be determined, preventive measures shall be formulated, operation safety risk control form shall be filled in and approved before operation. According to the degree of operational risk and possible consequences, the system also makes detailed provisions on the classification of risk assessment, the formulation principles of operational safety risk prevention measures, the filling and approval of operational safety risk control forms, and operational safety monitoring regulations.
As an important part of the internal management of the enterprise, the Operation Safety Risk Assessment and Control System has been incorporated into the internal control management system of CNPC and will be continuously revised and improved in future work. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31